Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15474065 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis
Condition: Endometriosis
Intervention: Drug: Rosiglitazone
2 Terminated Use of Rosiglitazone in the Treatment of Endometriosis
Condition: Endometriosis
Intervention: Drug: Rosiglitazone

Study has passed its completion date and status has not been verified in more than two years.